USUSDSep 28, 23:28
Abcellera Biologics Inc ABCL
About TRY 682.08 · converted at USD/TRY 49.0003, September 29, 2026, 15:27
- Volume
- 7.8M
- Day range
- 12.38 – 14.23
- Previous close
- 12.70
- Market cap
- USD 4.5B
Key Data
- Market cap
- USD 4.5B
- EPS
- USD −0.59
- 52 weeks
- 2.7814.23
- Day range
- 12.3814.23
- 1-year return
- 191.82%
- Previous close
- 12.70
- Open
- 12.44
- Volume
- 7.8M
- Avg. volume (200d)
- 5.9M
- Sector
- Healthcare
- Industry
- Biotechnology
Technical Signals
Technical signals
Only our Plus members can access this area.
AI Models
AI models
Only our Plus members can access this area.
About Abcellera Biologics Inc
Abcellera Biologics Inc (ABCL) last traded at 13.92 USD on the US stock market, a daily move of 9.61%. Converted at the USD/TRY rate of 49.0003 as of September 29, 2026, 15:27, this price equals about TRY 682.08; the conversion is for information only and the rate a broker applies may differ. Market capitalization is 4.5B USD, earnings per share −0.59 USD, the price-to-earnings ratio — and the dividend yield —. The company operates in the Healthcare sector, within the Biotechnology industry. The 52-week range is 2.78 – 13.92 USD; the one-year return is 191.82%.
Frequently Asked Questions
What is the ABCL stock price today?
Abcellera Biologics Inc (ABCL) last traded at 13.92 USD, a daily change of 9.61%. Prices are delayed by at least 15 minutes.
How much is Abcellera Biologics Inc (ABCL) stock in Turkish lira?
The last price of Abcellera Biologics Inc (ABCL) is USD 13.92. Converted at the USD/TRY rate of 49.0003 as of September 29, 2026, 15:27, that is about TRY 682.08. The conversion is for information only; trades use the exchange rate and fees your broker applies.
How can I buy US stocks from Türkiye?
US stocks such as Abcellera Biologics Inc (ABCL) can be bought through Turkish brokerage firms (aracı kurumlar) that offer access to foreign markets. You open an account enabled for foreign equity trading; because US stocks trade in dollars, the account and trades are in USD, so lira savings are converted to dollars first. The regular session on the NYSE and Nasdaq runs from 09:30 to 16:00 New York time, which is 16:30–23:00 Türkiye time while US daylight saving time is in effect and 17:30–00:00 otherwise. Taxation is subject to Turkish tax law; check the Revenue Administration (GİB) for current rules.
What are the P/E ratio and market cap of ABCL?
ABCL trades at a price-to-earnings ratio of —, with earnings per share of −0.59 USD and a market capitalization of 4.5B USD. Ratios use the latest reported results and the current price.
What is the 52-week range of ABCL?
Over the past 52 weeks ABCL traded between 2.78 and 13.92 USD; the one-year return is 191.82%.
Does ABCL pay a dividend?
The current dividend yield of ABCL is —. Dividend yield is the annual cash dividend divided by the share price; the company may change its policy.
What sector is Abcellera Biologics Inc in?
Abcellera Biologics Inc (ABCL) is listed on the US stock market; its sector is Healthcare and its industry is Biotechnology.
Where does the data on this page come from and how fresh is it?
Prices, volume and fundamentals come from licensed data providers; prices are delayed by at least 15 minutes and fundamentals refresh daily. AI forecasts are generated by Yatırımcı.AI models and are not investment advice.